Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Health Economics Review|July 26, 2015
Modeling rheumatoid arthritis using different techniques - a review of model construction and resultsStefan Scholz, Thomas MittendorfPharmacoeconomics|January 23, 2013
Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic reviewMartin Frank, Thomas MittendorfClinical Therapeutics|May 4, 2010
A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspectiveMark Nuijten, Thomas MittendorfHealth Economics Review|July 26, 2012
Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemiaThomas Plagemann, Anne Prenzler, Thomas MittendorfBMC Pediatrics|September 1, 2009
Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in GermanyDaniela Eidt-Koch, Thomas Mittendorf, Wolfgang GreinerExpert Opinion on Pharmacotherapy|August 28, 2004
Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritisSonja Merkesdal, Jörg Ruof, Thomas Mittendorf, et al.Dementia and Geriatric Cognitive Disorders Extra|May 17, 2012
Why is it so difficult to evaluate nursing interventions in dementia?Christoph Schwarzbach, Hans Förstl, Marc Nocon, et al.Health Economics Review|October 2, 2012
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspectiveJan Zeidler, Thomas Mittendorf, Rüdiger Müller, et al.Cancer Investigation|October 30, 2009
A structured review and guide through studies on health-related quality of life in kidney cancer, hepatocellular carcinoma, and leukemiaJia Liu, Thomas Mittendorf, J-Matthias von der SchulenburgMedizinische Klinik (Munich, Germany : 1983)|July 21, 2009
[Persistence and frequency of prescriptions of subcutaneous allergen-specific immunotherapy (SCIT) prescribed within the German statutory health insurance]Christa Claes, Thomas Mittendorf, J-Matthias Graf von der SchulenburgPageof 5